Robert Andtbacka on Managing Side Effects From T-VEC
Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Robert Andtbacka, MD, associate professor, Division of Surgical Oncology, Department of Surgery, University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Rigors and chills are quite common, but can be managed fairly easily. If a patient experiences these side effects, Andtbacka says, a physician should premeditate him or her with Tylenol and antihistamines in future treatments. After 5-7 injections, the side effects usually go away completely.
Overall, T-VEC is very well tolerated and most patients can go to work and continue with other everyday activities.